Literature DB >> 7480094

Determination of itraconazole and its metabolite in plasma using SPE-HPLC.

E Brandsteterová1, P Kubalec, A Rády, V Krcméry.   

Abstract

A SPE-HPLC procedure for the determination of itraconazole and its metabolite has been developed. The method was shown to be suitable for routine therapeutic monitoring in leukemic patients.

Entities:  

Mesh：

Substances：

Year:  1995        PMID： 7480094

Source DB:  PubMed          Journal:  Pharmazie        ISSN： 0031-7144            Impact factor:   1.267


  3 in total

1.  Development, validation, and routine application of a high-performance liquid chromatography method coupled with a single mass detector for quantification of itraconazole, voriconazole, and posaconazole in human plasma.

Authors:  Lorena Baietto; Antonio D'Avolio; Giusi Ventimiglia; Francesco Giuseppe De Rosa; Marco Siccardi; Marco Simiele; Mauro Sciandra; Giovanni Di Perri
Journal:  Antimicrob Agents Chemother       Date:  2010-06-07       Impact factor: 5.191

Review 2.  Optimisation of itraconazole therapy using target drug concentrations.

Authors:  J M Poirier; G Cheymol
Journal:  Clin Pharmacokinet       Date:  1998-12       Impact factor: 6.447

3.  Ultra-performance liquid chromatography electrospray ionization-tandem mass spectrometry method for the simultaneous determination of itraconazole and hydroxy itraconazole in human plasma.

Authors:  Ashish Dwivedi; Bhupinder Singh; Sandeep Sharma; R S Lokhandae; Naveen Dubey
Journal:  J Pharm Anal       Date:  2013-09-18
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.